August 8, 2014 1:10 PM

Salix shares fall six percent

Salix Pharmaceuticals shares were trading 6 percent lower Friday afternoon after the Raleigh drug company posted second-quarters results that failed to measure up to Wall Street's expectations. Some analysts, however, continued to be bullish on the company's prospects.

Related content